Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11054-11061
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11054
Figure 1
Figure 1 Speculative illustration. Speculative illustration of expected hepatitis C virus (HCV)-RNA load and transaminase flare during and after rituximab cyclophosphamide, hydroxydaunorubicin, vincristine, prednisolone (R-CHOP) immmunochemotherapy for a diffuse large B-cell lymphoma ideal patient (not cirrhotic, no other risk factors) experiencing transient toxicity. Curves and histograms reflect the average behavior of patients reported so far in the literature.